Seoul, South Korea

Yeong-Min Park

This inventor holds 1 USPTO granted patent. Top assignee: Dandi Bioscience Inc. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yeong-Min Park. Retrieved from https://idiyas.com/inventor/yeong-min-park-g84691a0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yeong-Min Park: Innovator in Influenza Virus Detection

Introduction

Yeong-Min Park is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of virology, particularly in the detection of highly pathogenic influenza viruses. His innovative work has implications for public health and disease prevention.

Latest Patents

Yeong-Min Park holds a patent for a "Marker for detecting highly pathogenic influenza virus and use thereof." This patent includes a marker that detects a highly pathogenic influenza virus, featuring a protein mutant created by substituting the amino acids 68 and 69 of a PB1-F2 protein. The patent also encompasses a composition for detecting the virus, a detection kit, and methods for screening antiviral substances against the influenza A virus.

Career Highlights

Yeong-Min Park is associated with Dandi Bioscience Inc., where he continues to advance research in the field of infectious diseases. His work is crucial in developing tools for early detection and treatment of influenza viruses.

Collaborations

Some of his notable coworkers include Kyun-Hwan Kim and Eun Sook Park, who contribute to the collaborative efforts in research and development at Dandi Bioscience Inc.

Conclusion

Yeong-Min Park's innovative contributions to influenza virus detection highlight the importance of research in combating infectious diseases. His work not only enhances our understanding of viral pathogens but also aids in the development of effective diagnostic tools.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…